Vaccine shows promise in treating high blood sugar for those with long COVID

SARS-CoV-2 infection of AGM reflects virologic, and immune response reported in humans. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-50339-4 Researchers at Tulane University have discovered a new approach to tackling a lingering health challenge faced by some with long-term COVID: high blood sugar levels. A new study published in Nature Communications and conducted at the Tulane National Primate Research Center suggests that the COVID-19 vaccine could be used therapeutically to address metabolic complications experienced among those with long-term COVID, sometimes called long-haulers, even if the vaccine is administered several days after infection. Many people who recover from COVID-19 continue to suffer Read More